The Evolution of Peptide Synthesis: From Early Days to Small Molecular Machines

ISSN: 1875-6646 (Online)
ISSN: 1573-4072 (Print)

Volume 13, 4 Issues, 2017

Download PDF Flyer

Current Bioactive Compounds

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Adriano Mollica
Department of Pharmacy, University ”G. d' Annunzio” of Chieti-Pescara
Via dei Vestini 31
Chieti, 66100

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

The Evolution of Peptide Synthesis: From Early Days to Small Molecular Machines

Current Bioactive Compounds, 9(3): 184-202.

Author(s): Adriano Mollica, Francesco Pinnen, Stefanucci Azzurra and Roberto Costante.

Affiliation: Dipartimento di Farmacia, Universita di Chieti-Pescara “G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy.


Peptides and proteins have been known for more than a century, but was only when du Vigneaud published the first synthesis of oxytocin, that the research on bioactive peptides was truly launched. Since then, the scientific progresses in the field have been astonishing and the synthesis of peptides of virtually any size and complexity is now possible. Perhaps the most important milestone was the development of the solid-phase peptide synthesis (SPPS) by Merrifield (1963), to revolutionize the field. In this critic review, we will analyze how the SPPS contributed to widespread the manufacture of peptides as active pharmaceuticals and what will be the challenges of tomorrow in this field.


SPPS, LPPS, fmoc-chemistry, molecular machine, native chemical ligation.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 3
First Page: 184
Last Page: 202
Page Count: 19
DOI: 10.2174/157340720903140119151919
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science